BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19714450)

  • 1. The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.
    Han YH; Park WH
    Mol Cell Biochem; 2010 Jan; 333(1-2):211-9. PubMed ID: 19714450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
    Park WH
    Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
    Park WH
    Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
    Han YH; Park WH
    Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiron, a ROS scavenger, protects human lung cancer Calu-6 cells against antimycin A-induced cell death.
    Han YH; Park WH
    Oncol Rep; 2009 Jan; 21(1):253-61. PubMed ID: 19082470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
    Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion.
    Park WH; You BR
    Int J Oncol; 2016 Feb; 48(2):813-20. PubMed ID: 26647857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis.
    Han YH; Park WH
    Lung Cancer; 2009 Aug; 65(2):150-60. PubMed ID: 19111365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
    Han YH; Moon HJ; You BR; Park WH
    Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
    Park WH
    Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
    You BR; Park WH
    Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of antimycin A on endothelial cells in cell death, reactive oxygen species and GSH levels.
    You BR; Park WH
    Toxicol In Vitro; 2010 Jun; 24(4):1111-8. PubMed ID: 20332020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes.
    You BR; Park WH
    Tumour Biol; 2013 Apr; 34(2):1145-53. PubMed ID: 23338718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.